Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
11 MG QD TO 15 MG QD PF-066497511件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
215 MG QD DE-escalated TO 7 MG QD PF-06649751 IN parent study remain AT 7 MG QD1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
33 MG QD TO 15 MG QD PF-066497511件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
47 MG QD TO 15 MG QD PF-066497511件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
5PF-066497511件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
6PF-06649751 - 15MG1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
7PF-06649751 - 1MG1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬
8PF-06649751 - 5MG1件: Tavapadon (PF-06649751)1件: Tavapadon 💬 2件: DRD1,
DRD5 💬 		12件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬1件: 6 💬